Skip to main navigation
  Menu

ASLAN Pharmaceuticals

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
EN
english中文

Investor Relations

Investor Relations

  • Investor Home
  • Corporate Information
  • Stock Information
  • News & Events
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Analyst Coverage
  • Shareholder Services

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Alerts sign up

Required fields denoted by an asterisk ().
Alert type

SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group View
Dec 20, 2017 DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Registration Statements
View HTML
0000950123-17-011452.pdf
0000950123-17-011452.rtf
0000950123-17-011452.xls
Jan 16, 2018 UPLOAD

UPLOAD

Other
View HTML
0000000000-18-001503.pdf
Jan 31, 2018 DRS/A

mendment to a previously filed DRS

Registration Statements
View HTML
0000950123-18-000530.pdf
0000950123-18-000530.rtf
0000950123-18-000530.xls
Feb 12, 2018 UPLOAD

UPLOAD

Other
View HTML
0000000000-18-004754.pdf
Feb 27, 2018 DRS/A

mendment to a previously filed DRS

Registration Statements
View HTML
0000950123-18-002736.pdf
0000950123-18-002736.rtf
0000950123-18-002736.xls
Mar 06, 2018 DRS/A

mendment to a previously filed DRS

Registration Statements
View HTML
0000950123-18-002848.pdf
0000950123-18-002848.rtf
0000950123-18-002848.xls
Mar 26, 2018 F-1

Registration statement for certain foreign private issuers

Registration Statements
View HTML
0001193125-18-095928.pdf
0001193125-18-095928.rtf
0001193125-18-095928.xls
Apr 13, 2018 F-6

Registration of depository shares evidenced by American Depository Receipts

Registration Statements
View HTML
0001193125-18-116628.pdf
0001193125-18-116628.rtf
0001193125-18-116628.xls
Apr 16, 2018 F-1/A

This filing is a pre-effective amendment to an F-1 filing

Registration Statements
View HTML
0001193125-18-117676.pdf
0001193125-18-117676.rtf
0001193125-18-117676.xls
Apr 16, 2018 FWP

FWP

Other
View HTML
0001193125-18-117683.pdf
0001193125-18-117683.rtf
0001193125-18-117683.xls

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Shareholder Tools

  • Print Page

    Print Page

  • RSS Feeds

    RSS Feeds

  • E-mail Alerts

    E-mail Alerts

Company

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
  • Terms and Conditions

Careers

For more information on employment opportunities at ASLAN, please contact us at careers@aslanpharma.com

Contact Us

Singapore Headquarters
83 Clemenceau Avenue
#12-03 UE Square
Singapore 239920
Tel: +65 6222 4235
Fax: +65 6225 2419

contact@aslanpharma.com